The most common outcomes for GLP-1 users are: Reduced appetite and feeling full or satiated longer Improved blood sugar Weight loss (of 1020% of body weight) Lets look at these outcomes in more detail
Cholecystectomy-induced alterations in bile acid composition and signaling are associated with hepatic steatosis, lipotoxicity, and dysbiosis, which may aggravate the progression of MASLD
Public health perspectives emphasise that while MTHFR mutations can influence folate metabolism and homocysteine levels, these genetic variations alone are not determinative of disease risk, and lifestyle and environmental factors play significant roles
Even if absorption is marginally improved, no clinical trials demonstrate that higher plasma glutathione during GLP-1 therapy improves weight loss outcomes, reduces oxidative stress markers, or enhances metabolic health
Physician owned & operated Your well-being is our priority